Literature DB >> 7707538

Transcriptional trans activation by human immunodeficiency virus type 1 Tat requires specific coactivators that are not basal factors.

C Suñé1, M A García-Blanco.   

Abstract

Expression of human immunodeficiency virus type 1 (HIV-1) genes is regulated by the trans activator Tat. Tat exerts its effects by increasing the rate of transcription, but the mechanism by which it does so is still unknown. To study the cellular factors required for Tat trans activation, we have expressed functional Gst-Tat fusion protein and used it to construct affinity columns. Our findings are as follows. (i) A Gst-Tat affinity matrix depleted HeLa nuclear extracts of a factor(s) required for Tat function. A Tat mutant bearing the missense mutation lysine to alanine at position 41 was incapable of this depletion. (ii) Tat trans activation was recovered by addition of unfractionated nuclear extract, the 0.5 M KCl elution fraction from the Tat affinity column, or sedimentation gradient fractions of HeLa extracts. The activity from the gradients sedimented with an apparent molecular mass of 200 kDa. (iii) Tat trans activation could not be recovered by use of recombinant human TATA-binding protein or partially purified TFIID. (iv) trans activation by Tat was blocked by heating of the nuclear extract under conditions in which basal transcription was not decreased. Our data demonstrate for the first time the existence of unique Tat coactivators distinct from factors required for general basal transcription.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7707538      PMCID: PMC189011     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  80 in total

1.  New human gene encoding a positive modulator of HIV Tat-mediated transactivation.

Authors:  H Shibuya; K Irie; J Ninomiya-Tsuji; M Goebl; T Taniguchi; K Matsumoto
Journal:  Nature       Date:  1992-06-25       Impact factor: 49.962

2.  The human cytomegalovirus 80-kilodalton but not the 72-kilodalton immediate-early protein transactivates heterologous promoters in a TATA box-dependent mechanism and interacts directly with TFIID.

Authors:  C Hagemeier; S Walker; R Caswell; T Kouzarides; J Sinclair
Journal:  J Virol       Date:  1992-07       Impact factor: 5.103

3.  HIV-1 Tat acts as a processivity factor in vitro in conjunction with cellular elongation factors.

Authors:  H Kato; H Sumimoto; P Pognonec; C H Chen; C A Rosen; R G Roeder
Journal:  Genes Dev       Date:  1992-04       Impact factor: 11.361

4.  Unusual structure of the human immunodeficiency virus type 1 trans-activation response element.

Authors:  R A Colvin; M A Garcia-Blanco
Journal:  J Virol       Date:  1992-02       Impact factor: 5.103

5.  Fasciola hepatica: molecular cloning, nucleotide sequence, and expression of a gene encoding a polypeptide homologous to a Schistosoma mansoni fatty acid-binding protein.

Authors:  J Rodríguez-Pérez; J R Rodríguez-Medina; M A García-Blanco; G V Hillyer
Journal:  Exp Parasitol       Date:  1992-06       Impact factor: 2.011

6.  Synergistic activation of the human immunodeficiency virus type 1 promoter by the viral Tat protein and cellular transcription factor Sp1.

Authors:  J Kamine; G Chinnadurai
Journal:  J Virol       Date:  1992-06       Impact factor: 5.103

7.  Composition of transcription factor B-TFIID.

Authors:  H T Timmers; R E Meyers; P A Sharp
Journal:  Proc Natl Acad Sci U S A       Date:  1992-09-01       Impact factor: 11.205

8.  Contribution of the TATA motif to Tat-mediated transcriptional activation of human immunodeficiency virus gene expression.

Authors:  H S Olsen; C A Rosen
Journal:  J Virol       Date:  1992-09       Impact factor: 5.103

9.  Inhibition of human immunodeficiency virus type 1 Tat activity by coexpression of heterologous trans activators.

Authors:  R Carroll; B M Peterlin; D Derse
Journal:  J Virol       Date:  1992-04       Impact factor: 5.103

10.  HIV-1 Tat protein promotes formation of more-processive elongation complexes.

Authors:  R A Marciniak; P A Sharp
Journal:  EMBO J       Date:  1991-12       Impact factor: 11.598

View more
  18 in total

1.  Spt5 cooperates with human immunodeficiency virus type 1 Tat by preventing premature RNA release at terminator sequences.

Authors:  Cyril F Bourgeois; Young Kyeung Kim; Mark J Churcher; Michelle J West; Jonathan Karn
Journal:  Mol Cell Biol       Date:  2002-02       Impact factor: 4.272

Review 2.  Regulation of HIV-1 transcription.

Authors:  K A Roebuck; M Saifuddin
Journal:  Gene Expr       Date:  1999

3.  Role for Fox-1/Fox-2 in mediating the neuronal pathway of calcitonin/calcitonin gene-related peptide alternative RNA processing.

Authors:  Hua-Lin Zhou; Andrew P Baraniak; Hua Lou
Journal:  Mol Cell Biol       Date:  2006-11-13       Impact factor: 4.272

4.  CA150, a nuclear protein associated with the RNA polymerase II holoenzyme, is involved in Tat-activated human immunodeficiency virus type 1 transcription.

Authors:  C Suñé; T Hayashi; Y Liu; W S Lane; R A Young; M A Garcia-Blanco
Journal:  Mol Cell Biol       Date:  1997-10       Impact factor: 4.272

5.  PITALRE, the catalytic subunit of TAK, is required for human immunodeficiency virus Tat transactivation in vivo.

Authors:  M O Gold; X Yang; C H Herrmann; A P Rice
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

6.  Regulation of P-glycoprotein by human immunodeficiency virus-1 in primary cultures of human fetal astrocytes.

Authors:  Tamima Ashraf; Patrick T Ronaldson; Yuri Persidsky; Reina Bendayan
Journal:  J Neurosci Res       Date:  2011-08-08       Impact factor: 4.164

7.  Activation of transcription factor NF-kappaB by the Tat protein of human immunodeficiency virus type 1.

Authors:  F Demarchi; F d'Adda di Fagagna; A Falaschi; M Giacca
Journal:  J Virol       Date:  1996-07       Impact factor: 5.103

8.  TAR RNA decoys inhibit tat-activated HIV-1 transcription after preinitiation complex formation.

Authors:  P R Bohjanen; Y Liu; M A Garcia-Blanco
Journal:  Nucleic Acids Res       Date:  1997-11-15       Impact factor: 16.971

9.  Inhibition of human immunodeficiency virus type 1 and type 2 Tat function by transdominant Tat protein localized to both the nucleus and cytoplasm.

Authors:  M J Orsini; C M Debouck
Journal:  J Virol       Date:  1996-11       Impact factor: 5.103

10.  A small circular TAR RNA decoy specifically inhibits Tat-activated HIV-1 transcription.

Authors:  P R Bohjanen; R A Colvin; M Puttaraju; M D Been; M A Garcia-Blanco
Journal:  Nucleic Acids Res       Date:  1996-10-01       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.